Andrea Soglian

Andrea Soglian has a diverse work experience in the pharmaceutical industry, spanning over 20 years. Currently, they hold the position of Senior Director of Medical Affairs at Mirum Pharmaceuticals, Inc. Prior to this role, they served as the Head of Medical Affairs for Orphalan in Europe. From 2018 to 2021, they worked at Akcea Therapeutics as the Medical Director for Italy and South Europe. Earlier in their career, Andrea worked at Novartis as the Therapeutic Area Medical Head for Immune & Rare diseases and Transplant. Andrea also played a significant role at Alexion Pharmaceuticals, where they served as an Associate Director in Medical Affairs Italy, responsible for starting up the company's medical team in Italy and overseeing various projects in clinical development and medical affairs. Andrea's career began at Bayer HealthCare, where they worked as a Medical Advisor, contributing to global clinical studies and providing support to marketing and sales efforts. Overall, Andrea's work experience reflects their expertise and leadership in medical affairs and clinical development in the pharmaceutical industry.

Andrea Soglian completed a Doctor of Medicine (MD) degree at the Università degli Studi di Milano from 1990 to 1997. Later, from 1998 to 2002, Andrea obtained a Specialist degree in Clinical Pharmacology specializing in Pharmaceutical Sciences from the same university.